Gesamtlänge aller Episoden: 11 days 12 hours 51 minutes
Kieran McCafferty, MB BChir, MRCP, MD (res) / Shelley Zieroth, MD, FRCPC, FHFSA (hon) - Handling Hyperkalaemia Without Compromising Care for Chronic Kidney Disease and Heart Failure
Javier Cortés, MD, PhD - Updates on HER3-Targeted Therapies in NSCLC and Breast Cancer
Michael K. Wong, MD, PhD, FRCPC - Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations
Johnny Mahlangu, MBBCH, MMed, FCPath - Redefining Balance in Hemophilia: Can We Restore Hemostasis by Inhibiting Anticoagulation?
P. James B. Dyck, MD - When ATTR Amyloidosis Strikes a Nerve: Best Practices in Timely Suspicion, Diagnosis, and Management of ATTR-Polyneuropathy
Michael Thorpy, MD - Dual Duty: Protecting Cardiovascular Health in Patients With Narcolepsy
Kevin Harrington, PhD, FRCR, FRCP - After More Than a Decade: Can We Now Enhance Treatment of Patients With LA SCCHN?
D. Ross Camidge, MD, PhD - Mastering MET and cMET and Recognizing Their Role in Advanced NSCLC
Sarah Jarvis, MBE, FRCGP - Identifying Intervention Points in CKD and HF From Multidisciplinary Viewpoints
Sorena Kiani, MBPhD, FRCP, FRCPath - Androgen Risk Reduction in Hereditary Angioedema: Why and How to Switch to Targeted Prophylactic Therapy?